Monash IVF Group Limited (ASX: MVF) - Share Price
Current share price for MVF : $0.725 0.005 (0.69%)+
Monash IVF Group Limited (MVF), an ASX-listed company, provides human fertility services and is one of the providers of Assisted Reproductive Services (ARS) which is the component of fertility care in Australia and South East Asia. ARS encompass a range of techniques used to assist patients experiencing infertility to achieve a clinical pregnancy including reproductive genetic services. In addition, the Group is a provider of women's imaging services.
MVF General Information +
| ASX Code | MVF |
| Website | http://monashivfgroup.com.au |
| Industry/Sector | Health Care Facilities |
| Market Cap ($M) | 282 |
| MVF Share Price | $0.725 |
| Day High | $0.730 |
| Day Low | $0.710 |
| Last Close | $0.720 |
| MVF Share Price Movement | $0.01 ( 0.69% ) |
Prices as at 16:40, 30 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Monash IVF Group Limited (MVF) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Result | 1.2¢ | 100% | 4 Mar 2026 | 10 Apr 2026 | - | - | - |
| Result | 2.6¢ | 100% | 6 Mar 2025 | 11 Apr 2025 | - | - | - |
| HFResult | 2.5¢ | 100% | 5 Sep 2024 | 11 Oct 2024 | - | - | - |
See all dividends from Monash IVF Group Limited (MVF) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Monash IVF Group Limited (MVF) price-sensitive announcements
MVF - Trading update
Monash IVF Group Limited has issued a trading update indicating that its expected FY26 Und
Monash IVF Group Limited (MVF)
12 Jun 2026 | 8:24 AM
12 Jun 2026 | 8:24 AM
MVF - Monash IVF rejects revised non-binding indicative proposal
Monash IVF Group Limited (ASX: MVF) has rejected a revised non-binding, indicative proposa
Monash IVF Group Limited (MVF)
20 Apr 2026 | 8:49 AM
20 Apr 2026 | 8:49 AM
MVF - Revised NBIO to acquire MVF
Monash IVF Group Limited received a revised non-binding indicative proposal from a consort
Monash IVF Group Limited (MVF)
13 Apr 2026 | 8:53 AM
13 Apr 2026 | 8:53 AM
MVF - 1H26 Results Presentation
The Monash IVF Group's 1H26 Results Presentation outlines a financial and operational perf
Monash IVF Group Limited (MVF)
26 Feb 2026 | 10:04 AM
26 Feb 2026 | 10:04 AM
Monash IVF Group Limited (MVF) Recent ASX Announcements
MVF Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2027F | C2 | $5.10 | 2.00% | 14.10 | 3.50 | 4.90% | 0.0% |
| 2026F | C2 | $5.00 | -22.60% | 14.40 | 2.50 | 3.50% | 0.0% |
| 2025A | $25.82 | $6.50 | -41.50% | 17.30 | 2.60 | 2.30% | 100.0% |
MVF Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 A | 2026 F | 2027 F | 2025 A | 2026 F | 2027 F | 2025 A | 2026 F | 2027 F | ||
| Monash IVF Group Limited (MVF) | $277M | -0.4154 | -0.2260 | 0.0200 | 10.9907 | 14.2000 | 13.9216 | 3.66% | 3.52% | 4.93% |
| Regis Healthcare Limited (REG) | $1,968M | -6.7687 | 0.0813 | 0.2360 | 36.7589 | 33.9948 | 27.5032 | 2.49% | 2.72% | 3.20% |
| Ramsay Health Care Limited (RHC) | $9,949M | 0.2153 | -0.1674 | 0.2395 | 27.4330 | 32.9486 | 26.5820 | 1.86% | 2.04% | 2.40% |
MVF Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.44 | 14.40 | 1.14 | 0.00 |
| Market | 0.56 | 17.10 | 1.55 | 0.97 |
| Sector | 0.67 | 22.30 | 1.60 | 2.48 |
MVF Directors
| Name | Position | Start Date |
|---|---|---|
| Dr Richard Charles Henshaw | Executive Director | 30 Apr 2014 |
| Mr Richard Hugh Davis | Non-Executive Chairman, Non-Executive Director | 4 Jun 2014 |
| Ms Zita Peach | Non-Executive Director | 12 Oct 2016 |
| Dr Dwayne Crombie | Non-Executive Director | 24 Nov 2025 |
| Mr Neil John Broekhuizen | Non-Executive Director | 4 Jun 2014 |
| Ms Catherine Jane West | Non-Executive Director | 8 Sep 2020 |
| Ms Catherine (Cathy) Ann Aston | Non-Executive Director | 26 Feb 2024 |
| Ms Victoria Atkinson | Non-Executive Director | 5 Jan 2026 |
Monash IVF Group Limited (MVF) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 29 Dec 2025 | ASTON, Catherine (Cathy) | Sell | Indirect Shares | 75,000 | $0.719 | $53,928.710 |
| 16 Sep 2024 | ASTON, Catherine (Cathy) | Buy | Direct Shares | 2,000 | $1.211 | $2,422.597 |
| 16 Sep 2024 | ASTON, Catherine (Cathy) | Buy | Indirect Shares | 75,000 | $1.211 | $90,847.403 |
See all changes in directors' interest & trades for Monash IVF Group Limited (MVF) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
MVF Management
| Name | Position |
|---|---|
| Johannes Lagerwij | Asia Managing Director |
| Peggy North | Chief Corporate Shared Services Officer |
| Tedd Fuell | Chief Governance and Risk Officer |
| Thierry Panthier | Chief Information Officer |
| Rebecca Redden | Chief Operating Officer |
| Deirdre Zander Fox | Chief Scientific Officer |
| Rebecca Dean | Company Secretary,General Counsel |
| Luk Rombauts | Group Medical Director |
MVF Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Monash IVF Group Limited (MVF). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 37,767,969 (9.69%) | Washington H. Soul Pattinson and Company Limited |
| 24,375,402 (6.26%) | Argo Investments Limited |
| 19,725,471 (5.06%) | Regal Funds Management Pty Ltd |
MVF Calendar of Events
| Date | Event |
|---|---|
| 25 February 2027 | Report (Interim) |
| 19 October 2026 | Report (Annual) |
| 21 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
